Bioethics 34 (2):200-202 (2020)

In a recent article, Marilyn Baffoe-Bonnie offers three arguments for conducting CRISPR/Cas9 biotechnology research to cure sickle-cell disease (SCD) based on addressing historical and current injustices in SCD research and care. I show that her second and third arguments suffer from roughly the same defect, which is that they really argue for something else rather than for conducting CRISPR/Cas9 research in particular for SCD. For instance, the second argument argues that conducting this gene therapy research would improve the relationship between SCD sufferers (who are mostly of African descent) and health care providers. But really what is essential in improving this relationship is for those providers to genuinely care and be concerned, and this could be lacking even with the CRISPR research being done. Indeed, this relationship could be improved even without that research being done, as long as there is genuine concern. Thus, this argument actually argues for the need for genuine concern. As for the third argument, one (of two) problems arises because it claims that CRISPR research for SCD should be pursued because the benefits would be shared by even non-research-participants, as non-participants would be encouraged. However, this argues for any research for SCD, not for CRISPR research in particular. I conclude that a better justice-based argument will use only Baffoe-Bonnie’s first argument, which is based on historic neglect of a cure for SCD.
Keywords CRISPR  benefit‐sharing  biotechnology  distributive justice  gene therapy  sickle cell disease
Categories (categorize this paper)
DOI 10.1111/bioe.12690
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

 PhilArchive page | Other versions
Through your library

References found in this work BETA

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Reproductive CRISPR Does Not Cure Disease.Tina Rulli - 2019 - Bioethics 33 (9):1072-1082.
Human Gene Therapy and the Slippery Slope Argument.Veikko Launis - 2002 - Medicine, Health Care and Philosophy 5 (2):169-179.
The Mechanism and Applications of CRISPR-Cas9.Paul Scherz - 2017 - The National Catholic Bioethics Quarterly 17 (1):29-36.


Added to PP index

Total views
106 ( #101,203 of 2,448,270 )

Recent downloads (6 months)
5 ( #143,970 of 2,448,270 )

How can I increase my downloads?


My notes